Brodalumab (AMG 827) is a human monoclonal IgG2 antibody targeting the interleukin 17 receptor (IL-17R), commonly used as an immunosuppressant in treating psoriasis.
CAS Number:
[1174395-19-7]
Target:
IL Receptor
* VAT and and shipping costs not included. Errors and price changes excepted